ReviewTherapeutic advances in hematology2019

The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma.

Sarah Tomassetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.